Cargando…

Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease

Alternative splicing (AS) is a complex coordinated transcriptional regulatory mechanism. It affects nearly 95% of all protein-coding genes and occurs in nearly all human organs. Aberrant alternative splicing can lead to various neurological diseases and cancers and is responsible for aging, infectio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Pingping, Lu, Luying, Cai, Shasha, Chen, Jianghua, Lin, Weiqiang, Han, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416054/ https://www.ncbi.nlm.nih.gov/pubmed/34484216 http://dx.doi.org/10.3389/fimmu.2021.713540

Ejemplares similares

Significance of PD1 Alternative Splicing in Celiac Disease as a Novel Source for Diagnostic and Therapeutic Target
por: Ponce de León, Candelaria, et al.
Publicado: (2021)

SIRT1: A Potential Therapeutic Target in Autoimmune Diseases
por: Shen, Pan, et al.
Publicado: (2021)

Natural Killer Cells: Potential Biomarkers and Therapeutic Target in Autoimmune Diseases?
por: Gianchecchi, Elena, et al.
Publicado: (2021)

Pyroptosis and Its Role in Autoimmune Disease: A Potential Therapeutic Target
por: You, Ruixuan, et al.
Publicado: (2022)

Immune Checkpoints as Therapeutic Targets in Autoimmunity
por: Paluch, Christopher, et al.
Publicado: (2018)

Extensive Alternative Splicing of KIR Transcripts
por: Bruijnesteijn, Jesse, et al.
Publicado: (2018)

Semaphorins in Angiogenesis and Autoimmune Diseases: Therapeutic Targets?
por: Iragavarapu-Charyulu, Vijaya, et al.
Publicado: (2020)

Age/autoimmunity-associated B cells in inflammatory arthritis: An emerging therapeutic target
por: Li, Zhen-yu, et al.
Publicado: (2023)

Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic Targets
por: Porazinski, Sean, et al.
Publicado: (2018)

Alternative Splicing of FOXP3—Virtue and Vice
por: Mailer, Reiner K. W.
Publicado: (2018)

TIGIT as a Promising Therapeutic Target in Autoimmune Diseases
por: Yue, Chenran, et al.
Publicado: (2022)

The role of inflammation in autoimmune disease: a therapeutic target
por: Xiang, Yu, et al.
Publicado: (2023)

Therapeutic Potential of Hyporesponsive CD4(+) T Cells in Autoimmunity
por: Maggi, Jaxaira, et al.
Publicado: (2015)

Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential
por: Dankers, Wendy, et al.
Publicado: (2017)

Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity
por: Van Kaer, Luc, et al.
Publicado: (2018)

Krüppel-like Factor 15: A Potential Therapeutic Target For Kidney Disease
por: Wang, Lefeng, et al.
Publicado: (2019)

Potential Therapeutic Targets of B7 Family in Colorectal Cancer
por: Wang, Changgang, et al.
Publicado: (2020)

Alternative Splicing: A New Therapeutic Target for Ovarian Cancer
por: Yao, Shijie, et al.
Publicado: (2022)

Therapeutic targeting of alternative splicing to inhibit hepatocellular carcinoma metastasis
por: Lee, Yun-Han
Publicado: (2022)

The regulatory role of alternative splicing in inflammatory bowel disease
por: Zhou, Jianli, et al.
Publicado: (2023)

The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
por: Raker, Verena Katharina, et al.
Publicado: (2016)

Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases
por: Zhai, Yujia, et al.
Publicado: (2021)

GARP as a Therapeutic Target for the Modulation of Regulatory T Cells in Cancer and Autoimmunity
por: Zimmer, Niklas, et al.
Publicado: (2022)

Therapeutic Applications of Targeted Alternative Splicing to Cancer Treatment
por: Lin, Jung-Chun
Publicado: (2017)

Modulation of nuclear REST by alternative splicing: a potential therapeutic target for Huntington's disease
por: Chen, Guo‐Lin, et al.
Publicado: (2017)

Complement Therapeutics in Autoimmune Disease
por: Thurman, Joshua M., et al.
Publicado: (2019)

Pathogenesis of Autoimmune Cytopenias in Inborn Errors of Immunity Revealing Novel Therapeutic Targets
por: Cortesi, Manuela, et al.
Publicado: (2022)

The Therapeutic and Pathogenic Role of Autophagy in Autoimmune Diseases
por: Yin, Heng, et al.
Publicado: (2018)

Therapeutic Potential of ω-3 Polyunsaturated Fatty Acids in Human Autoimmune Diseases
por: Li, Xiaoxi, et al.
Publicado: (2019)

Immunological Characteristics of Alternative Splicing Profiles Related to Prognosis in Bladder Cancer
por: Ye, Fangdie, et al.
Publicado: (2022)

Alternative RNA splicing in cancer: what about adult T-cell leukemia?
por: Tram, Julie, et al.
Publicado: (2022)

Tuning the Functionality by Splicing: Factor H and Its Alternative Splice Variant FHL-1 Share a Gene but Not All Functions
por: Mannes, Marco, et al.
Publicado: (2020)

The Role of Intestinal Mucosal Barrier in Autoimmune Disease: A Potential Target
por: An, Jia, et al.
Publicado: (2022)

Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools
por: Martínez-Montiel, Nancy, et al.
Publicado: (2017)

Alternative RNA splicing: contribution to pain and potential therapeutic strategy
por: Donaldson, Lucy F., et al.
Publicado: (2016)

Post-Translational Modifications of STING: A Potential Therapeutic Target
por: Kang, Jiaqi, et al.
Publicado: (2022)

Editorial: Therapeutic potential of innate and innate-like effector lymphocytes in autoimmune and inflammatory diseases
por: Wu, Lan, et al.
Publicado: (2023)

Tuning of NK-Specific HLA-C Expression by Alternative mRNA Splicing
por: Goodson-Gregg, Frederick J., et al.
Publicado: (2020)

The Alternatively Spliced Isoforms of Key Molecules in the cGAS-STING Signaling Pathway
por: Liang, Jiaqian, et al.
Publicado: (2021)

Potential Implications of Quercetin in Autoimmune Diseases
por: Shen, Pan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rbb81r64ohnjc74i55ft0bq7p4